Alix Beith
About Alix Beith
Alix Beith has over 12 years of experience in international public health in a number of technical, program management, and geographical areas. For Health Systems 20/20, her technical foci include pharmaceutical management, tuberculosis, HIV/AIDS, and health policy and financing. As an independent international public health consultant contracted through Broad Branch Associates, she is currently leading development of a paper on risk and causal factors of drug resistance for the Center for Global Development. Other recent undertakings include acting as a coordinator for the Health Systems Action Network (HSAN), developing fact sheets on selected innovative financing mechanisms for health, developing a report on contraceptive security in the context of decentralization and integration in Latin America and the Caribbean, and surveying and development of status reports for OGAC targeted evaluation studies. Previously, Alix worked for Management Sciences for Health, where her main focus was desktop research, survey/policy analysis, and development of policy recommendations regarding interventions to improve case detection and adherence to TB and HIV medicines. Alix has a bachelor's degree in biology and French from Tufts University and a M.Sc. in health policy, planning, and financing from the London School of Economics and the London School of Hygiene and Tropical Medicine. She is fluent in Spanish and French. (Source: http://www.healthsystems2020.org/section/about/bios/staff_bios)
Role(s) / Profession(s)
- Freelance, Independent
Organization
- United States Agency International Development - USAID
Work Location(s)
- United States
Language(s)
- English
- French
- Spanish
Recent Contributions
-

Alix Beith replied to "Giving incentives/enablers according to treatment adherence rates" in the MDR-TB Treatment & Prevention community.
Dear colleagues, This is a very welcome discussion! I would like to invite your readers to take a look at a recent chapter on the subject of incentives and TB. The topic is not only adherence to TB meds, but also incentives to improve case detection rates - please see ...
Recent Recommendations
- None at this time.
